Casey C. Kopczynski
2019
In 2019, Casey C. Kopczynski earned a total compensation of $2M as Chief Scientific Officer at Aerie Pharmaceuticals, a 16% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $139,896 |
|---|---|
| Option Awards | $1,038,845 |
| Salary | $435,000 |
| Stock Awards | $344,560 |
| Other | $7,613 |
| Total | $1,965,914 |
Kopczynski received $1M in option awards, accounting for 53% of the total pay in 2019.
Kopczynski also received $139.9K in non-equity incentive plan, $435K in salary, $344.6K in stock awards and $7.6K in other compensation.
Rankings
In 2019, Casey C. Kopczynski's compensation ranked 6,016th out of 13,971 executives tracked by ExecPay. In other words, Kopczynski earned more than 56.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,016 out of 13,971 | 57th |
Division Manufacturing | 2,255 out of 5,701 | 60th |
Major group Chemicals And Allied Products | 814 out of 2,200 | 63rd |
Industry group Drugs | 687 out of 1,886 | 64th |
Industry Biological Products, Except Diagnostic Substances | 163 out of 389 | 58th |
Source: SEC filing on April 24, 2020.
Kopczynski's colleagues
We found five more compensation records of executives who worked with Casey C. Kopczynski at Aerie Pharmaceuticals in 2019.
2019
Vicente Anido
Aerie Pharmaceuticals
Chief Executive Officer
2019
Thomas Mitro
Aerie Pharmaceuticals
Chief Operating Officer
2019
John LaRocca
Aerie Pharmaceuticals
General Counsel
2019
Richard Rubino
Aerie Pharmaceuticals
Chief Financial Officer
2019
David Hollander
Aerie Pharmaceuticals
Chief Research and Development Officer
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019